<DOC>
	<DOCNO>NCT02330978</DOCNO>
	<brief_summary>Bone marrow-derived mesenchymal stem cell ( MSC ) therapy promise treatment several degenerative disease , include retinopathy glaucoma , however previous safety study involve human conduct . The objective study evaluate effect autologous bone marrow-derived MSC transplantation worst eye 10 patient legal bilateral blindness due glaucoma . Primary outcome type severity adverse effect . Secondary outcome change visual field , visual acuity , optical coherence tomography , retinal ganglion cell function .</brief_summary>
	<brief_title>Intravitreal Mesenchymal Stem Cell Transplantation Advanced Glaucoma .</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Retinal Degeneration</mesh_term>
	<criteria>Diagnosis Advanced Bilateral OpenAngle Glaucoma ; Best correct visual acuity le 0,1 good eye ; Social cognitive ability participate . Severe systemic morbidity ; Other ocular blind condition associate ; Impossibility perform propose examination .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>